Medical News

RSS

FDA may set patient safety regulations for health IT

The Huffington Post Investigative Fund: "In the past two years, the agency has received reports of six patient deaths and several dozen injuries linked to malfunctions in the systems, Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, said in testimony prepared for a government hearing on Thursday. ... The FDA has been studying the issue for several years. Its latest concerns are surfacing as the government ramps up an ambitious plan to spend as much as $27 billion in stimulus money helping doctors and hospitals across the country purchase electronic medical records systems that rely on digital software rather than paper medical charts."

25 Feb 2010

AOSSM and RTI Biologics award $250,000 grant for ligament and tendon repair and regeneration research

Dr. Robert C. Bray of the University of Calgary was recently selected as the winner of the American Orthopaedic Society for Sports Medicine's (AOSSM) $250,000 Ligament and Tendon Repair and Regeneration Grant for his project, "Biological Augmentation of Ligament and Tendon Healing: Role of Neuropeptides."

25 Feb 2010

PositiveID, FIS partner to launch Health Link personal health record

PositiveID Corporation announced today that it has entered into a partnership with FIS™, one of the world’s largest providers of banking and payments technology, to launch the Company’s next generation Health Link personal health record (“Health Link”).

25 Feb 2010

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Pfizer Inc. announced today that the United States Food and Drug Administration has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company’s 13-valent pneumococcal conjugate vaccine.

25 Feb 2010

Doctors work fewer hours, study finds

A new study finds that doctors are working fewer hours even as the shortage of primary care physicians persists.

25 Feb 2010

SBi's Mini-Rail System and Cannulated Screw System receive FDA pre-market clearance

Small Bone Innovations, Inc. (SBi), a leading, privately-held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, announced that it has received 510(k) pre-market clearance notifications from the U.S. Food and Drug Administration (FDA) for Mini-Rail Fixation System (‘Mini-Rail System’) and large Cannulated Screw System for use in lower limb reconstruction and repair procedures.

25 Feb 2010

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient's lifetime.

25 Feb 2010

Obama, GOP clash over summit starting point; Voters note partisan divide

The Obama administration says its health overhaul proposal is a starting point, not a final word, Reuters reports. "It is important to understand that this proposal isn't meant to be the final say on the legislation,' Nancy-Ann DeParle, director of the White House Office of Health Reform, said in an email."

25 Feb 2010

Special Issue of Business Horizons addresses issues central to healthcare and life sciences

A recent Special Issue of Business Horizons (www.elsevier.com/locate/bushor), the journal of the Kelley School of Business, Indiana University, and published by Elsevier, addresses issues central to healthcare and life sciences. Healthcare reform, for example, has been at the center of U.S. political debate in recent years with renewed attempts to gain bipartisan support from Congress for passage of a national system of health insurance coverage.

25 Feb 2010

Current health reform debate haunted by health bills of the past

Key provisions of the 1993 Republican bill, introduced by Sen. John Chafee, R-R.I., with 19 other Republicans and two Democrats, "may seem familiar, as they bear a strong resemblance to those in the current Democratic Senate bill, and now in President Barack Obama's proposal," Kaiser Health News reports. "A mandate that individuals buy insurance, subsidies for the poor to buy insurance and the requirement that insurers offer a standard benefits package and refrain from discriminating based on pre-existing conditions were all in the 1993 GOP bill."

25 Feb 2010

Anadys Pharmaceuticals' ANA598 combination demonstrates 73% cEVR in ongoing Phase II study for HCV

Anadys Pharmaceuticals, Inc. today announced preliminary results from an ongoing Phase II study demonstrating that 73% of hepatitis C patients treated with 200 mg ANA598 twice daily in combination with pegylated interferon and ribavirin (SOC) achieved undetectable levels of virus (<15 IU/mL) at week 12, known as complete Early Virological Response or cEVR.

25 Feb 2010

Study examines range of health issues and trends among older women in California

Older women who are divorced, separated or widowed or who have never married have twice the uninsured rate of their married peers, according to a new policy brief from the UCLA Center for Health Policy Research.

25 Feb 2010

MedNet Solutions introduces iMedNet eClinical technology platform

MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce iMedNet™, the company's ground-breaking new electronic data capture (EDC)/eClinical technology platform.

24 Feb 2010

The Democrats' 2010 health reform plan evokes 1993 Republican bill

Kaiser Health News Maggie Mertens spoke to former Sen. Dave Durenberger, R-Minn., about his take on past and present health reform politics. In 1993, at the height of President Bill Clinton's health care reform initiative, Sen. John Chafee, R-R.I., along with 19 other Republicans and two Democrats, put forth a bill which was considered the major GOP proposal.

24 Feb 2010

Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.

24 Feb 2010

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

As part of John Muir Health’s Minimally Invasive Thoracic Surgery program, a minimally invasive thymectomy – removal of the thymus gland – was successfully performed recently at the John Muir Medical Center – Concord Campus. This procedure, designed to minimize trauma to patients, uses the latest generation da Vinci® Si Surgical System to help surgeons see vital anatomical structures more clearly and to perform a more precise operation.

24 Feb 2010

House to vote on ending insurer antitrust exemption today, White House backs measure

The Obama administration is supporting a House bill that would end the federal antitrust exemption for health insurers.

24 Feb 2010

Democrats revisit reconciliation as means to pass overhaul

Reconciliation, a parliamentary tactic that could allow Congress to pass health reform with a simple Senate majority, was dismissed weeks ago by centrist Democrats, but some of those lawmakers are now warming to the approach, clearing a possible avenue for passage of the overhaul, Politico reports. "Obviously, if the minority is just frustrating the process, that argues for taking steps to get the public's business done," said Sen. Evan Bayh, D-Ind., one of the senators to reverse course on reconciliation (Budoff Brown, 2/23).

24 Feb 2010

Researchers to test Radio-embolisation technique in patients with bowel cancer

Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.

24 Feb 2010

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon’s PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

24 Feb 2010

Medical News

FDA may set patient safety regulations for health IT

AOSSM and RTI Biologics award $250,000 grant for ligament and tendon repair and regeneration research

PositiveID, FIS partner to launch Health Link personal health record

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine

Doctors work fewer hours, study finds

SBi's Mini-Rail System and Cannulated Screw System receive FDA pre-market clearance

Researchers develop evaluation tool to help guide asymptomatic pancreatic cyst treatment

Obama, GOP clash over summit starting point; Voters note partisan divide

Special Issue of Business Horizons addresses issues central to healthcare and life sciences

Current health reform debate haunted by health bills of the past

Anadys Pharmaceuticals' ANA598 combination demonstrates 73% cEVR in ongoing Phase II study for HCV

Study examines range of health issues and trends among older women in California

MedNet Solutions introduces iMedNet eClinical technology platform

The Democrats' 2010 health reform plan evokes 1993 Republican bill

Welichem commences enrollment in WBI-1001 Phase IIa clinical trial for psoriasis

Minimally Invasive Thoracic Surgery program performed at John Muir Medical Center

House to vote on ending insurer antitrust exemption today, White House backs measure

Democrats revisit reconciliation as means to pass overhaul

Researchers to test Radio-embolisation technique in patients with bowel cancer

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News